EX-23.2 2 tm2327633d1_ex23-2.htm EXHIBIT 23.2

Exhibit 23.2

 

 

 

 

Baker Tilly US, LLP

4807 Innovate Ln.

PO Box 7398

Madison, WI 53707-7398

 

T: +1 (608) 249 6622

F: +1 (608) 249 8532

 

bakertilly.com

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated March 9, 2023, relating to the consolidated financial statements of Cellectar Biosciences, Inc. (the Company), which appears in the Company's Annual Report on Form 10-K for the year ended December 31, 2022. Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company’s ability to continue as a going concern.

 

We also consent to the reference to us under the heading “Experts” in such Registration Statement.

 

 

 

Madison, Wisconsin

October 5, 2023